𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Safe use of sorafenib in a patient undergoing salvage liver transplantation for recurrent hepatocellular carcinoma after hepatic resection

✍ Scribed by Richard Kim; Narayanan Menon; Federico Aucejo

Book ID
107577240
Publisher
Springer US
Year
2010
Tongue
English
Weight
260 KB
Volume
28
Category
Article
ISSN
1357-0560

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

High pathological risk of recurrence aft
High pathological risk of recurrence after surgical resection for hepatocellular carcinoma: An indication for salvage liver transplantation
✍ Margarita Sala; Josep Fuster; Josep M. Llovet; Miquel Navasa; Manel SolΓ©; MarΓ­a πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 99 KB

Surgical resection and liver transplantation offer a 5-year survival greater than 70% in patients with hepatocellular carcinoma, but the high recurrence rate impairs long-term outcome after resection. Pathological data such as vascular invasion and detection of additional nodules predict recurrence

Recurrence of hepatocellular carcinoma a
Recurrence of hepatocellular carcinoma and hepatitis B reinfection in hepatitis B surface antigen–positive patients after liver transplantation
✍ Sammy Saab; Melina Yeganeh; Kelvin Nguyen; Francisco Durazo; Steven Han; Hasan Y πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 207 KB

Hepatitis B virus (HBV) reinfection and recurrence of hepatocellular carcinoma (HCC) after orthotopic liver transplantation (OLT) are associated with increased graft failure and reduced patient survival. We evaluated the effects of both HCC recurrence and HBV reinfection on the long-term survival of

Effect of viral status on recurrence aft
Effect of viral status on recurrence after liver resection for patients with hepatitis B virus–related hepatocellular carcinoma
✍ Shoji Kubo; Kazuhiro Hirohashi; Hiromu Tanaka; Tadashi Tsukamoto; Taichi Shuto; πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 English βš– 94 KB πŸ‘ 3 views

## Background: Risk factors for recurrence after resection of hepatitis b virus (hbv)-related hepatocellular carcinoma (hcc) require more precise definition. ## Methods: Forty patients who underwent liver resection for hbv-related hcc were studied. their clinical findings, laboratory data (includ

Efficacy and safety of sorafenib in comb
Efficacy and safety of sorafenib in combination with mammalian target of rapamycin inhibitors for recurrent hepatocellular carcinoma after liver transplantation
✍ Carlos Gomez-Martin; Javier Bustamante; Javier F. Castroagudin; Magdalena Salced πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 185 KB πŸ‘ 1 views

There is currently no consensus on the most suitable treatment for the recurrence of hepatocellular carcinoma (HCC) after liver transplantation. This open, multicenter, retrospective, uncontrolled cohort study was designed to evaluate the safety and preliminary efficacy of the combined use of a mamm

Use of sorafenib in patients with hepato
Use of sorafenib in patients with hepatocellular carcinoma before liver transplantation: A cost-benefit analysis while awaiting data on sorafenib safety
✍ Alessandro Vitale; Michael L. Volk; Davide Pastorelli; Sara Lonardi; Fabio Farin πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 361 KB πŸ‘ 1 views

The role of bridging therapies for patients with hepatocellular carcinoma (HCC) on the waiting list for liver transplantation (LT) remains controversial. There is strong evidence to support the effectiveness of sorafenib in extending the time to progression of HCC. Using a Markov model, we compared